Company: CNDT
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001677703-25-000076
Chunk: 72

Company: CONDUENT Inc
Filing Date: 2025-05-07
Form: 10-Q
Item: Part II, Item 3
Chunk 72
---
ITEM 3 — DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4 — MINE SAFETY DISCLOSURES

None.

CNDT Q1 2025 Form 10-Q33

Table of Contents 

ITEM 5 — OTHER INFORMATION

10b5-1 Plans 

During the three months ended March 31, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).

CNDT Q1 2025 Form 10-Q34

Table of Contents 

ITEM 6 — EXHIBITS 

Incorporated by ReferenceExhibit No.DescriptionFiled HerewithFormExhibit No.Filing Date2.1Custodial Transfer and Purchase Agreement, between Conduent Business Services, LLC and HealthEquity, Inc., dated as of September 18, 2023.8-K2.19/19/20232.2First Amendment to Custodial Transfer and Purchase Agreement, between Conduent Business Services, LLC and HealthEquity, Inc., dated as of March 7, 2024.10-Q2.28/7/20243.1Restated Certificate of Incorporation of Registrant filed with the Department of the State of New York on December 31, 2016.8-K3.112/23/20163.2Amended and Restated By-Laws of Registrant as amended through October 31, 2023.10-Q3.211/1/202310.1Letter Agreement dated May 16, 2024 between Conduent Incorporated and Michael McDaniel.X10.6(a)(i)Form of Restricted Stock Unit Award Agreement 2025 under the 2021 PIP.X10.6(a)(ii)Form of Performance Stock Unit Award Agreement 2025 (Adjusted Revenue Growth) under the 2021 PIP.X10.6(a)(iii)Form of Performance Stock Unit Award Agreement 2025 for CEO and CFO (Adjusted Revenue Growth CEO and CFO) under the 2021 PIP.X10.6(a)(iv)Form of Performance Stock Unit Award Agreement 2025 (rTSR) under the 202